Hormonal Contraception Update
- Paru S. David, MD,
- Elizabeth A. Boatwright, MD,
- Beverly S. Tozer, MD,
- Deepa P. Verma, MD,
- Janis E. Blair, MD,
- Anita P. Mayer, MD and
- Julia A. Files, MD
- From the Division of Women's Health Internal Medicine (P.S.D., E.A.B., B.S.T., D.P.V., J.A.F.), Division of Infectious Diseases (J.E.B.), and Division of Community Internal Medicine (A.P.M.), Mayo Clinic College of Medicine, Scottsdale, Ariz
- Address reprint requests and correspondence to Paru S. David, MD, Division of Women's Health Internal Medicine, Mayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85259 (e-mail: david.paru{at}mayo.edu).
Abstract
Unintended pregnancy continues to be a serious public health issue in the United States. Of the 3 million unplanned pregnancies per year, 60% occur in women using some form of contraception. Educating and helping women choose a contraceptive agent that best suits their needs will improve compliance and contraceptive efficacy. A multitude of new contraceptive agents are now available. We review new hormonal contraceptive options and discuss newer oral agents, extended-cycle contraception, and innovative delivery methods.
Footnotes
-
A question-and-answer section appears at the end of this article.
- © 2006 Mayo Foundation for Medical Education and Research
